Phospholipase D Stimulation by Receptor Tyrosine Kinases Mediated by Protein Kinase C and a Ras/Ral Signaling Cascade
Overview
Affiliations
Stimulation of phospholipase D (PLD) in HEK-293 cells expressing the M(3) muscarinic receptor by phorbol ester-activated protein kinase C (PKC) apparently involves Ral GTPases. We report here that PKC, but not muscarinic receptor-induced PLD stimulation in these cells, is strongly and specifically reduced by expression of dominant-negative RalA, G26A RalA, as well as dominant-negative Ras, S17N Ras. In contrast, overexpression of the Ras-activated Ral-specific guanine nucleotide exchange factor, Ral-GDS, specifically enhanced PKC-induced PLD stimulation. Moreover, recombinant Ral-GDS potentiated Ral-dependent PKC-induced PLD stimulation in membranes. Epidermal growth factor, platelet-derived growth factor, and insulin, ligands for receptor tyrosine kinases (RTKs) endogenously expressed in HEK-293 cells, apparently use the PKC- and Ras/Ral-dependent pathway for PLD stimulation. First, PLD stimulation by the RTK agonists was prevented by PKC inhibition and PKC down-regulation. Second, expression of dominant-negative RalA and Ras mutants strongly reduced RTK-induced PLD stimulation. Third, overexpression of Ral-GDS largely potentiated PLD stimulation by the RTK agonists. Finally, using the Ral binding domain of the Ral effector RLIP as an activation-specific probe for Ral proteins, it is demonstrated that endogenous RalA is activated by phorbol ester and RTK agonists. Taken together, strong evidence is provided that RTK-induced PLD stimulation in HEK-293 cells is mediated by PKC and a Ras/Ral signaling cascade.
Aktories K, Gierschik P, Heringdorf D, Schmidt M, Schultz G, Wieland T Naunyn Schmiedebergs Arch Pharmacol. 2019; 392(8):887-911.
PMID: 31101932 DOI: 10.1007/s00210-019-01650-1.
Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamine.
Bernfeld E, Menon D, Vaghela V, Zerin I, Faruque P, Frias M J Biol Chem. 2018; 293(42):16390-16401.
PMID: 30194281 PMC: 6200938. DOI: 10.1074/jbc.RA118.004972.
Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.
Bruntz R, Lindsley C, Brown H Pharmacol Rev. 2014; 66(4):1033-79.
PMID: 25244928 PMC: 4180337. DOI: 10.1124/pr.114.009217.
The ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosis.
Scotland R, Allen L, Hennings L, Post G, Post S PLoS One. 2013; 8(9):e73599.
PMID: 24069211 PMC: 3775766. DOI: 10.1371/journal.pone.0073599.
RalGDS-dependent cardiomyocyte autophagy is required for load-induced ventricular hypertrophy.
Rifki O, Bodemann B, Battiprolu P, White M, Hill J J Mol Cell Cardiol. 2013; 59:128-38.
PMID: 23473774 PMC: 3647008. DOI: 10.1016/j.yjmcc.2013.02.015.